NASDAQ | DRNA

$12.49 + 0.54 (+4.519%)

3 month stock price graph

4:00 PM ET on Feb 23, 2018 Pricing delayed 20 minutes

Investors & Media

Download Library

 
Download Library
Date Document Type
Feb 14, 2018 LEERINK Partners 7th Annual Global Healthcare Conference
Presentations
Jan 30, 2018 Noble Capital Markets' Fourteenth Annual Investor Conference Presentation
Presentations
Jan 10, 2018 Dicerna Pharmaceuticals Corporate Overview January 2018
Presentations
Oct 26, 2017 GalXC TM RNAi Platform Enables Potent and Durable RNAi-Mediated Inhibition of Hepatitis B Virus in Preclinical Models
Presentations
Jul 15, 2017 DCR-PHXC:A new approach for treating all Primary Hyperoxalurias by inhibiting LDHA
Presentations
Jul 14, 2017 Oxalate Production in Primary Hyperoxaluria Types 1, 2 and 3 and the Role of LDH in the Liver
Presentations
Jul 14, 2017 PHYOS: An Observational Study of Patients with Primary Hyperoxaluria Type 1
Presentations
May 15, 2017 Dicerna US Tides May 2017 Presentation
Presentations
Apr 17, 2017 GalXC cGMP Manufacturing Experience Presentation
Presentations
Feb 23, 2017 Asia Tides 2017 Presentation - GalXC Research Update
Presentations
Page:
1
NextLast
= add file to Briefcase